Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Winners of the Medical Research Foundation's second Festive Science Image Competition, run in partnership with the Medical Research Council (MRC), have been announced today.

This annual competition invites Foundation and MRC-funded researchers, staff, and students to produce a science image with direct relevance to medical research, combined with a festive theme. The competition's judges, who work in science, medical research, communications, and public engagement, were looking for eye-catching, high-quality images, along with a clear explanation for non-scientific audiences.

Three winners were selected, with the Department of Oncology's Nathalie Lovgren and Iain Tullis winning third place for their entry 'Starry Winter Night'. 

"Radiotherapy is one of the main methods used to treat cancer,” say Nathalie and Iain. “FLASH radiotherapy is an emerging technique offering the same damage to tumours as standard radiotherapy, whilst potentially reducing side effects.

"A tree of lead, attached to a water flask, were both exposed to FLASH radiation,” Nathalie and Iain explain. “The dazzling image resembles the starry nights bringing us light during the cold winter months. The lead blocks most of the radiation, and the colour specs are due to the radiation interacting with the camera sensor. The blue glow is Cherenkov radiation, which appears when charged particles move faster in water than light itself."

The first-place image, by Michaela Raab, PhD student at the MRC Human Genetics Unit, University of Edinburgh, will feature on the Medical Research Foundation and MRC's joint Season's Greetings card for 2023. The cards can be ordered online, with a suggested donation to the Foundation.

Similar stories

MSc Medical Physics with Radiobiology receives IPEM accreditation

The Department of Oncology at the University of Oxford is delighted to announce that our new MSc Medical Physics with Radiobiology programme has received Masters Level Accreditation from the Institute of Physics and Engineering Medicine (IPEM).

Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer

The Oncology Department at the University of Oxford is excited to announce the forthcoming publication in the Proceedings of the National Academy of Sciences (PNAS) of the research paper “Goblet Cell Differentiation Subgroups in Colorectal Cancer.” This groundbreaking study sheds light on the role of goblet cell differentiation in colorectal cancer (CRC) and its impact on cancer progression and prognosis.

Ground-breaking Study reveals previously unknown genetic causes of Colorectal Cancer

A pioneering study, led by UK universities, including the University of Oxford, The Institute of Cancer Research, London, the University of Manchester and the University of Leeds, has provided the most comprehensive analysis to date of the genetic makeup of colorectal cancer (CRC).

Subashan Vadibeler wins 2024 Lasker Essay Contest

Subashan Vadibeler, a recent Oxford Rhodes scholar and Department of Oncology student, is one of five co-winners of the international 2024 Lasker Essay Contest, sponsored by the Lasker Foundation.

Glowing dye helps surgeons eradicate prostate cancer

A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study led by the University of Oxford.

New funding for development of world's first lung cancer vaccine

Oxford and UCL researchers seeking to create the world’s first vaccine to prevent lung cancer in people at high risk of the disease have been granted up to £1.7 million from Cancer Research UK and the CRIS Cancer Foundation.